Global eClinical Solutions Market is Expected to Reach $21.50 Billion by 2031, States the Report by Allied Market Research

Significant surge in number of diseases that led to drug development, improved data visibility provided by eClinical solutions, and availability of improved research infrastructure are expected to drive the growth of the global eClinical solutions market. Immense data scale from the healthcare industry, surge in the number of clinic trials, and increased focus on clinical research by government during COVID-19 pandemic had a negative impact on the growth of the market.

/EIN News/ -- Portland, OR, Aug. 16, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global eClinical solutions market generated $6.82 billion in 2021, and is projected to reach $21.50 billion by 2031, growing at a CAGR of 12.2% from 2022 to 2031. The report offers a detailed analysis of the top winning strategies, evolving market trends, market size and estimations, value chain, key investment pockets, drivers & opportunities, competitive landscape and regional landscape. The report is a useful source of information for new entrants, shareholders, frontrunners and shareholders in introducing necessary strategies for the future and taking essential steps to significantly strengthen and heighten their position in the market.

Download Report (245 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/2118

COVID-19 Scenario:

• The outbreak of COVID-19 has had a positive impact on the growth of the global eClinical solutions market, owing to the occurrence of lockdowns in various countries across the globe.
• Lockdowns resulted in the increased demand for clinical trials as more and more people were increasingly being contracted by the fatal COVID-19 infection. Thus, the number of clinical research activities initiated by professionals surged exponentially.
• These research activities were essentially carried out to determine the efficacy of the deadly virus and the effective drugs for the treatment of the COVID-19 infections. Thus, the demand for eClinical solutions surged rapidly.
• Besides, increased government emphasis and investment on clinical research further accelerated the growth of the market. Thus, the COVID-19 pandemic has had a positive impact on the growth of the market.

Report coverage & details:

Report Coverage	Details
Forecast Period	2022­–2031
Base Year	2021
Market Size in 2021	$6.82 billion
Market Size in 2031	$21.50 billion
CAGR	12.2%
No. of Pages in Report	358
Segments covered	Product, delivery mode, clinical trial phase, end user, and region.
Drivers	Significant surge in number of diseases that led to drug development
	Availability of improved research infrastructure
Opportunities	Improved data visibility provided by eClinical solutions
	Persistent technological advancements
Restrains	Extortionate cost of implementation
	Long approval time for clinical trials

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/request-for-customization/2118?reqfor=covid

The report offers a detailed segmentation on the global eClinical solutions market based on product, delivery mode, clinical trial phase, end user, and region.

Based on product, the electronic data capture and clinical data management systems segment held the dominating market share in 2021, holding more than one-fourth of the global market, and is expected to maintain its leadership status during the forecast period. The electronic clinical outcome assessment segment, on the other hand, is expected to cite the fastest CAGR of 13.4% during the forecast period.

Based on delivery mode, the web-hosted segment held the dominating market share in 2021, holding more two-fifths of the global eClinical solutions market. The cloud-based segment, on the other hand, is expected to cite the fastest CAGR of 13.4% during the forecast period. In addition, the same segment is expected to maintain its leadership status in terms of revenue during the forecast period.

Based on clinical trial phase, the phase II segment held the largest market share in 2021, holding nearly one-third of the global market, and is expected to maintain its leadership status during the forecast period. The phase I segment, on the other hand, is expected to cite the fastest CAGR of 13.0% during the forecast period.

Purchase Inquire: https://www.alliedmarketresearch.com/purchase-enquiry/2118

Based on end user, the contract research organizations segment held the dominating market share in 2021, holding nearly half of the global eClinical solutions market, and is expected to maintain its leadership status during the forecast period. In addition, the same segment is expected to cite the fastest CAGR of 12.6% during the forecast period. The report also analyzes the segments including pharmaceutical and biopharmaceutical companies and others.

Based on region, the market across North America held the largest market share in 2021, holding more than two-fifths of the global market, and is expected to maintain its leadership status during the forecast period. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 13.2% during the forecast period.

The key players analyzed in the global eClinical solutions market include Oracle Corporation, Parexel International Corporation (Calyx), DataTrak International, Inc., Dassault Systèmes (Medidata Solution, Inc.), Clario, Signant Health (CRF Health Inc.), IBM Watson Health, and Veeva Systems.

The report analyzes these key players of the global eClinical solutions market. These market players have made effective use of strategies such as joint ventures, collaborations, expansion, new product launches, partnerships, and others to maximize their foothold and prowess in the industry. The report is helpful in analyzing recent developments, product portfolio, business performance and operating segments by prominent players of the market.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount + Covid-19 scenario):

Oncology/Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

3D Cell Culture Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

HIV Drugs Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Electrocardiograph (ECG) Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Disposable Gloves Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Surgical Robotics Market - Global Opportunity Analysis and Industry Forecast, 2021–2030

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.